Impact of Pistachio Consumption on Sleep

Last updated: February 11, 2026
Sponsor: Columbia University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Control food

Pistachio

Clinical Study ID

NCT07218822
AAAV9510
  • Ages 45-64
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Sleep is essential for life and overall health. Unfortunately, a large portion of the population in the U.S. and worldwide experience sleep deficiencies, which increase their risk for developing chronic diseases. These sleep difficulties often cause distress, leading individuals to seek various forms of treatment. Given that some drugs cause habituation and undesirable side effects, individuals often turn to over-the-counter sleep remedies. However, long-term use of over-the-counter treatments is not recommended by the American Academy of Sleep Medicine for insomnia treatment and there is currently no recommendation related to dietary management. There is a strong need to identify natural measures to improve sleep in millions of adults battling poor sleep. Diet is emerging as a potentially important modulator of sleep. Despite observational data linking greater nut intake with better sleep, and that pistachios contain a significant number of sleep-promoting compounds, no study to date has evaluated the impact of pistachio supplementation on sleep. To address this key knowledge gap, the investigators propose to conduct a randomized controlled trial to evaluate the impact of pistachio consumption, relative to a calorie-matched control food, on sleep in middle-aged adults with poor sleep and to explore underlying mechanisms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Poor sleep quality, Pittsburgh Sleep Quality Index score >5

  • BMI 20 - 29.9 kg/m^2

  • Ability to abstain from travel across time zones

  • Willingness to eat study foods

  • Willingness/ability to discontinue use of vitamin and mineral supplements

Exclusion

Exclusion Criteria:

  • Premenopausal women

  • Medical or living conditions that could affect sleep:

  • Smoking

  • Excessive caffeine intake (>300 mg/day)

  • Non-day shift work

  • Chronic pain

  • Diagnosis of a chronic disease (e.g., uncontrolled hypertension, pre-diabetes,type 2 diabetes, chronic kidney disease, chronic obstructive pulmonary disease)

  • Autoimmune diseases, cardiovascular event or cancer in the past 24 months

  • Psychiatric/neurologic disease or disorder, or sleep disorder (diagnosed or highrisk for sleep apnea, chronic insomnia, restless leg syndrome, narcolepsy)

  • Allergy or intolerance to nuts or study foods

  • Use of medications that influence CYP1A2 and selective serotonin reuptake inhibitors

Study Design

Total Participants: 28
Treatment Group(s): 2
Primary Treatment: Control food
Phase:
Study Start date:
December 12, 2025
Estimated Completion Date:
August 31, 2027

Connect with a study center

  • Columbia University Irving Medical Center

    New York 5128581, New York 5128638 10032
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.